Literature DB >> 8416378

Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.

R L Ward1, M M McNeal, D S Sander, H B Greenberg, D I Bernstein.   

Abstract

Natural infection by very similar strains of rotavirus during the 1988-1989 rotavirus season in Cincinnati, Ohio, provided complete protection of young children against subsequent rotavirus illnesses for a period of at least 2 years. Using this limited strain variability, we characterized the association between the titers of antibody to either the VP4 or the VP7 neutralization protein and protection against subsequent rotavirus disease. This was done by using reassortants that contained only one of the two rotavirus neutralization proteins of 89-12, a culture-adapted isolate representative of the protective rotavirus strains. The other neutralization protein in these reassortants was derived from a heterologous rotavirus (WC3 or EDIM) to which the infected subjects made little or no neutralizing antibody (titers, < or = 20). The geometric mean titer (GMT) of antibody to 89-12 in convalescent-phase sera from the 21 subjects analyzed was 2,323. The GMT of antibody to a reassortant (strain WC-4) that contained the VP7 protein of 89-12 and VP4 of WC3 was 387. In contrast, the GMT of antibody to a reassortant (strain EDIM-7) that contained the VP4 protein of 89-12 and the VP7 protein of EDIM was 1,078. Thus, the major neutralization response was directed against VP4 rather than VP7, a finding that has important implications for development of appropriate rotavirus vaccines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416378      PMCID: PMC237383     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3.

Authors:  R D Shaw; D L Stoner-Ma; M K Estes; H B Greenberg
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

2.  Efficiency of human rotavirus propagation in cell culture.

Authors:  R L Ward; D R Knowlton; M J Pierce
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Three-dimensional structure of rotavirus.

Authors:  B V Prasad; G J Wang; J P Clerx; W Chiu
Journal:  J Mol Biol       Date:  1988-01-20       Impact factor: 5.469

4.  Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.

Authors:  A R Kalica; H B Greenberg; R G Wyatt; J Flores; M M Sereno; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

5.  Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.

Authors:  R L Ward; D R Knowlton; G M Schiff; Y Hoshino; H B Greenberg
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Identification of the two rotavirus genes determining neutralization specificities.

Authors:  P A Offit; G Blavat
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.

Authors:  K Y Green; A Z Kapikian
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Isolation and characterization of two distinct human rotavirus strains with G6 specificity.

Authors:  G Gerna; A Sarasini; M Parea; S Arista; P Miranda; H Brüssow; Y Hoshino; J Flores
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody.

Authors:  R L Ward; M M McNeal; J F Sheridan
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

View more
  21 in total

1.  Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.

Authors:  Serenella Arista; Giovanni M Giammanco; Simona De Grazia; Stefania Ramirez; Concetta Lo Biundo; Claudia Colomba; Antonio Cascio; Vito Martella
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Antigenic and genomic diversity of human rotavirus VP4 in two consecutive epidemic seasons in Mexico.

Authors:  L Padilla-Noriega; M Méndez-Toss; G Menchaca; J F Contreras; P Romero-Guido; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; J Calva; M L Guerrero; B S Coulson; H B Greenberg; S López; C F Arias
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea.

Authors:  Nonkululeko B Magagula; Mathew D Esona; Martin M Nyaga; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Mapaseka L Seheri; A Duncan Steele; David E Wentworth; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2014-05-20       Impact factor: 2.327

4.  Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.

Authors:  N A Cunliffe; J S Gondwe; S M Graham; B D Thindwa; W Dove; R L Broadhead; M E Molyneux; C A Hart
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Production of reassortant viruses containing human rotavirus VP4 and SA11 VP7 for measuring neutralizing antibody following natural infection.

Authors:  R J Gorrell; R F Bishop
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

6.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

7.  Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.

Authors:  S Ishida; N Feng; B Tang; J M Gilbert; H B Greenberg
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.

Authors:  Ningguo Feng; Liya Hu; Siyuan Ding; Mrinmoy Sanyal; Boyang Zhao; Banumathi Sankaran; Sasirekha Ramani; Monica McNeal; Linda L Yasukawa; Yanhua Song; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

9.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

10.  Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.

Authors:  K Johansen; L Granqvist; K Karlén; G Stintzing; I Uhnoo; L Svensson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.